Payden & Rygel’s ASML ASML Stock Holding History

Payden & Rygel’s Portfolio ASML Stock Details ASML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-103	Closed	-$9K	–	159
2015 Q4	$9K	Buy	+103	New	+$9.38K	﹤0.01%	187

Other funds holding ASML

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

HJGA

Hardman Johnston Global Advisors Stamford, Connecticut $2.1B AUM 41.89% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Payden & Rygel's ASML Position: Q1 2016 in Review

Payden & Rygel sold out of ASML (ASML) in Q1 2016, closing a stake of 103 shares — an estimated $9K sold.

Payden & Rygel first reported a position in ASML in Q4 2015 and held it in 1 quarter. The position peaked at $9K in Q4 2015. 187 funds tracked by Wall St. Rank hold ASML as of Q1 2016.

Payden & Rygel reported no remaining ASML position as of Q1 2016 after selling out during the quarter.
Payden & Rygel sold 103 ASML shares in Q1 2016, an estimated $9K.
Payden & Rygel first reported a position in ASML in Q4 2015 and held it in 1 quarter.
Payden & Rygel's ASML position peaked at $9K in Q4 2015.
187 funds tracked by Wall St. Rank held ASML as of Q1 2016.

Based on Payden & Rygel's 13F filing for Q1 2016, filed 6 May 2016.